Clinical Trial Update: A Long-term Follow up Study of EXG102-031 in Patients With wAMD (Everest LTFU) [Phase 1]

View source ↗

Summary

Clinical trial update on EXG102-031 long-term follow-up in patients with neovascular age-related macular degeneration (wet AMD); Phase 1 study currently active …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neovascular Age-related Macular Degeneration

Drugs mentioned

• EXG102-031

Snippet

Sponsor: Exegenesis Bio | Conditions: Neovascular Age-Related Macular Degeneration (nAMD), Neovascular (Wet) Age-related Macular Degeneration (AMD) | Phase 1 | Status: ACTIVE_NOT_RECRUITING